GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly innovation in how we approach type 2 diabetes . These new drugs work by stimulating the body’s inherent GLP-1 hormone , https://digibookmarks.com/story21678869/glp-1-a-significant-advance-in-glucose-care